Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Aug 1;184(2):315–324. doi: 10.1084/jem.184.2.315

Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes

PMCID: PMC2192744  PMID: 8760785

Abstract

An RNA containing 2'-amino pyrimidines has been isolated using in vitro selection techniques that specifically and avidly (apparent Kd approximately 30 nM) binds a mouse monoclonal antibody called MA20. This 2'-amino-derivatized RNA is at least 10,000-fold more stable than unmodified RNA in serum, and can act as a decoy and block MA20 binding to its natural antigen, the human insulin receptor, on lymphocytes. Furthermore, this RNA decoy can inhibit MA20-mediated downmodulation of insulin receptor expression on human lymphocytes in culture by up to 90%. Surprisingly, the decoy RNA cross-reacts with autoantibodies from patients with extreme insulin resistance and can inhibit these antiinsulin receptor antibodies from downmodulating insulin receptor expression by up to 80% without impeding insulin binding to its receptor. These results suggest that in vitro-selected decoy RNAs may be able to specifically and selectively block oligoclonal autoimmune responses to self-antigens in patients with autoimmune diseases.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aurup H., Williams D. M., Eckstein F. 2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry. 1992 Oct 13;31(40):9636–9641. doi: 10.1021/bi00155a016. [DOI] [PubMed] [Google Scholar]
  2. Bartel D. P., Zapp M. L., Green M. R., Szostak J. W. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell. 1991 Nov 1;67(3):529–536. doi: 10.1016/0092-8674(91)90527-6. [DOI] [PubMed] [Google Scholar]
  3. Conrad R., Keranen L. M., Ellington A. D., Newton A. C. Isozyme-specific inhibition of protein kinase C by RNA aptamers. J Biol Chem. 1994 Dec 23;269(51):32051–32054. [PubMed] [Google Scholar]
  4. Doudna J. A., Cech T. R., Sullenger B. A. Selection of an RNA molecule that mimics a major autoantigenic epitope of human insulin receptor. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2355–2359. doi: 10.1073/pnas.92.6.2355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flier J. S., Kahn C. R., Roth J., Bar R. S. Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance. Science. 1975 Oct 3;190(4209):63–65. doi: 10.1126/science.170678. [DOI] [PubMed] [Google Scholar]
  6. Forsayeth J. R., Montemurro A., Maddux B. A., DePirro R., Goldfine I. D. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation. J Biol Chem. 1987 Mar 25;262(9):4134–4140. [PubMed] [Google Scholar]
  7. Gavin J. R., 3rd, Gorden P., Roth J., Archer J. A., Buell D. N. Characteristics of the human lymphocyte insulin receptor. J Biol Chem. 1973 Mar 25;248(6):2202–2207. [PubMed] [Google Scholar]
  8. Gold L., Polisky B., Uhlenbeck O., Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem. 1995;64:763–797. doi: 10.1146/annurev.bi.64.070195.003555. [DOI] [PubMed] [Google Scholar]
  9. Jaeger J. A., Turner D. H., Zuker M. Improved predictions of secondary structures for RNA. Proc Natl Acad Sci U S A. 1989 Oct;86(20):7706–7710. doi: 10.1073/pnas.86.20.7706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jellinek D., Green L. S., Bell C., Lynott C. K., Gill N., Vargeese C., Kirschenheuter G., McGee D. P., Abesinghe P., Pieken W. A. Potent 2'-amino-2'-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry. 1995 Sep 12;34(36):11363–11372. doi: 10.1021/bi00036a009. [DOI] [PubMed] [Google Scholar]
  11. Jellinek D., Lynott C. K., Rifkin D. B., Janjić N. High-affinity RNA ligands to basic fibroblast growth factor inhibit receptor binding. Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11227–11231. doi: 10.1073/pnas.90.23.11227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Joyce G. F. Amplification, mutation and selection of catalytic RNA. Gene. 1989 Oct 15;82(1):83–87. doi: 10.1016/0378-1119(89)90033-4. [DOI] [PubMed] [Google Scholar]
  13. Kosmakos F. C., Roth J. Insulin-induced loss of the insulin receptor in IM-9 lymphocytes. A biological process mediated through the insulin receptor. J Biol Chem. 1980 Oct 25;255(20):9860–9869. [PubMed] [Google Scholar]
  14. Lee S. W., Gallardo H. F., Gaspar O., Smith C., Gilboa E. Inhibition of HIV-1 in CEM cells by a potent TAR decoy. Gene Ther. 1995 Aug;2(6):377–384. [PubMed] [Google Scholar]
  15. Lee S. W., Gallardo H. F., Gilboa E., Smith C. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain. J Virol. 1994 Dec;68(12):8254–8264. doi: 10.1128/jvi.68.12.8254-8264.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lin Y., Qiu Q., Gill S. C., Jayasena S. D. Modified RNA sequence pools for in vitro selection. Nucleic Acids Res. 1994 Dec 11;22(24):5229–5234. doi: 10.1093/nar/22.24.5229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lisziewicz J., Rappaport J., Dhar R. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. New Biol. 1991 Jan;3(1):82–89. [PubMed] [Google Scholar]
  18. Pieken W. A., Olsen D. B., Benseler F., Aurup H., Eckstein F. Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. Science. 1991 Jul 19;253(5017):314–317. doi: 10.1126/science.1857967. [DOI] [PubMed] [Google Scholar]
  19. Roth R. A., Maddux B. A., Cassell D. J., Goldfine I. D. Regulation of the insulin receptor by a monoclonal anti-receptor antibody. Evidence that receptor down regulation can be independent of insulin action. J Biol Chem. 1983 Oct 25;258(20):12094–12097. [PubMed] [Google Scholar]
  20. Schaefer E. M., Siddle K., Ellis L. Deletion analysis of the human insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomeric alpha-subunit. J Biol Chem. 1990 Aug 5;265(22):13248–13253. [PubMed] [Google Scholar]
  21. Schneider D., Tuerk C., Gold L. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. J Mol Biol. 1992 Dec 5;228(3):862–869. doi: 10.1016/0022-2836(92)90870-p. [DOI] [PubMed] [Google Scholar]
  22. Smith D., Kirschenheuter G. P., Charlton J., Guidot D. M., Repine J. E. In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. Chem Biol. 1995 Nov;2(11):741–750. doi: 10.1016/1074-5521(95)90102-7. [DOI] [PubMed] [Google Scholar]
  23. Smith D., Kirschenheuter G. P., Charlton J., Guidot D. M., Repine J. E. In vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase. Chem Biol. 1995 Nov;2(11):741–750. doi: 10.1016/1074-5521(95)90102-7. [DOI] [PubMed] [Google Scholar]
  24. Soos M. A., Siddle K., Baron M. D., Heward J. M., Luzio J. P., Bellatin J., Lennox E. S. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J. 1986 Apr 1;235(1):199–208. doi: 10.1042/bj2350199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation. J Virol. 1991 Dec;65(12):6811–6816. doi: 10.1128/jvi.65.12.6811-6816.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sullenger B. A., Gallardo H. F., Ungers G. E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell. 1990 Nov 2;63(3):601–608. doi: 10.1016/0092-8674(90)90455-n. [DOI] [PubMed] [Google Scholar]
  27. Szostak J. W. In vitro genetics. Trends Biochem Sci. 1992 Mar;17(3):89–93. doi: 10.1016/0968-0004(92)90242-2. [DOI] [PubMed] [Google Scholar]
  28. Taylor S. I., Barbetti F., Accili D., Roth J., Gorden P. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor. Endocrinol Metab Clin North Am. 1989 Mar;18(1):123–143. [PubMed] [Google Scholar]
  29. Tian Y., Adya N., Wagner S., Giam C. Z., Green M. R., Ellington A. D. Dissecting protein:protein interactions between transcription factors with an RNA aptamer. RNA. 1995 May;1(3):317–326. [PMC free article] [PubMed] [Google Scholar]
  30. Tsai D. E., Keene J. D. In vitro selection of RNA epitopes using autoimmune patient serum. J Immunol. 1993 Feb 1;150(3):1137–1145. [PubMed] [Google Scholar]
  31. Tsai D. E., Kenan D. J., Keene J. D. In vitro selection of an RNA epitope immunologically cross-reactive with a peptide. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):8864–8868. doi: 10.1073/pnas.89.19.8864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 3;249(4968):505–510. doi: 10.1126/science.2200121. [DOI] [PubMed] [Google Scholar]
  33. Tuerk C., MacDougal S., Gold L. RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6988–6992. doi: 10.1073/pnas.89.15.6988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Zhang B., Roth R. A. A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9858–9862. doi: 10.1073/pnas.88.21.9858. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES